Login
Products
Login
Home
Alerts
Search
Watchlist
Products

S H Kelkar & Company Ltd

SHK
NSE
145.82
0.63%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

S H Kelkar & Company Ltd

SHK
NSE
145.82
0.63%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,018Cr
Close
Close Price
145.82
Industry
Industry
Chemicals - Others
PE
Price To Earnings
11.87
PS
Price To Sales
0.88
Revenue
Revenue
2,286Cr
Rev Gr TTM
Revenue Growth TTM
10.45%
PAT Gr TTM
PAT Growth TTM
4,222.14%
Peer Comparison
How does SHK stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SHK
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
472423455472513470543543567581554584
Growth YoY
Revenue Growth YoY%
4.81.810.022.68.711.319.115.210.523.52.17.5
Expenses
ExpensesCr
405355384396424392462479494508501528
Operating Profit
Operating ProfitCr
676872769078816573735356
OPM
OPM%
14.216.115.716.117.416.614.911.912.912.69.59.6
Other Income
Other IncomeCr
-201221-119200613133
Interest Expense
Interest ExpenseCr
71010101010131413131414
Depreciation
DepreciationCr
212122222222242325262727
PBT
PBTCr
1938414659-73642797371249
Tax
TaxCr
1811111424122410-611316
PAT
PATCr
128303233-87401810326933
Growth YoY
PAT Growth YoY%
-91.719.819.5140.52,858.4-412.032.0-45.5206.6129.4-77.086.3
NPM
NPM%
0.26.66.66.86.5-18.57.33.218.14.41.75.6
EPS
EPS
0.22.02.22.42.5-6.32.91.37.41.90.72.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
8369259811,0211,0441,1141,3221,5641,6871,8412,1232,286
Growth
Revenue Growth%
10.76.04.12.26.818.618.37.89.215.37.6
Expenses
ExpensesCr
7187758158639129561,0861,3501,4691,5381,8262,031
Operating Profit
Operating ProfitCr
118150166158132158236215217303297255
OPM
OPM%
14.116.216.915.512.714.217.813.712.916.514.011.2
Other Income
Other IncomeCr
2510121328-27366-96-3898
Interest Expense
Interest ExpenseCr
1920541425171624404953
Depreciation
DepreciationCr
2930192431526272808695105
PBT
PBTCr
9511015314311554194132104183115195
Tax
TaxCr
24374851271950-1741594125
PAT
PATCr
70731059388361441496312474170
Growth
PAT Growth%
3.843.5-11.7-5.1-59.2301.53.8-57.996.7-40.2129.3
NPM
NPM%
8.47.910.79.18.43.210.99.63.76.73.57.4
EPS
EPS
5.35.47.36.56.22.610.510.84.58.95.312.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
132145145145145141141138138138138138
Reserves
ReservesCr
3685716677127196838108759261,0741,1341,191
Current Liabilities
Current LiabilitiesCr
3802502473644805755747257099341,1311,157
Non Current Liabilities
Non Current LiabilitiesCr
544118589180370478411254281318
Total Liabilities
Total LiabilitiesCr
9441,0081,0771,2801,4451,4901,8982,2972,2222,4022,6852,805
Current Assets
Current AssetsCr
6157106976987708081,0441,2321,2071,3631,5761,556
Non Current Assets
Non Current AssetsCr
3282973805816756828541,0651,0161,0391,1091,249
Total Assets
Total AssetsCr
9441,0081,0771,2801,4451,4901,8982,2972,2222,4022,6852,805

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
6286102103772051955019710716
Investing Cash Flow
Investing Cash FlowCr
-17-77-104-164-137-40-149-160-103-82-72
Financing Cash Flow
Financing Cash FlowCr
-7-24-162849-1968812-175899
Net Cash Flow
Net Cash FlowCr
37-14-17-33-11-31134-97-813443
Free Cash Flow
Free Cash FlowCr
406364-17-392051997814947-80
CFO To PAT
CFO To PAT%
87.7118.397.6111.687.9572.2135.633.6312.486.821.3
CFO To EBITDA
CFO To EBITDA%
52.457.761.765.358.5129.782.723.490.535.45.3

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
03,2764,3083,7382,2191,0971,5791,9871,3752,8412,460
Price To Earnings
Price To Earnings
0.044.941.139.825.130.710.913.422.523.233.6
Price To Sales
Price To Sales
0.03.54.43.62.11.01.21.30.81.51.1
Price To Book
Price To Book
0.04.65.34.42.61.31.72.01.32.31.9
EV To EBITDA
EV To EBITDA
1.221.826.024.519.08.78.311.98.911.210.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.944.545.444.943.443.443.240.840.444.143.7
OPM
OPM%
14.116.216.915.512.714.217.813.712.916.514.0
NPM
NPM%
8.47.910.79.18.43.210.99.63.76.73.5
ROCE
ROCE%
15.816.518.114.410.86.814.38.77.611.97.8
ROE
ROE%
14.110.212.910.810.24.315.114.85.910.25.8
ROA
ROA%
7.57.39.77.26.12.47.66.52.85.22.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** S H Kelkar & Company Ltd (SHK) is India’s largest homegrown Fragrance & Flavour (F&F) company, with over **100 years of industry experience**. The company operates under the **SHK**, **Cobra**, and **Keva** brands, offering a comprehensive portfolio of **fragrances, flavours, natural ingredients, aroma chemicals, and specialty extracts**. It serves a diverse, global client base across **FMCG, personal care, pharmaceuticals, food & beverages, home care, and fine fragrances**. With a strong presence in **India, Europe, Southeast Asia, and the U.S.**, SHK combines **deep regional insights, advanced R&D, and vertically integrated manufacturing** to deliver customized solutions that align with evolving consumer trends. --- ### **Business Segments & Revenue Mix** - **Fragrance Segment**: Dominates revenue, contributing **~91%** in FY24–25 (up from ~88% in prior years). Products used in personal care, fabric care, home care, fine fragrances, and industrial applications like ambient scents for automobiles and consumer durables. - **Flavours Segment**: Accounts for the remaining **~9%** of revenue. Supplies certified (FSSAI, USFDA, Halal) flavors to dairy, beverages, bakery, savory foods, and pharmaceuticals. - **Global Ingredients**: A rapidly recovering segment benefiting from **supply chain de-risking trends**, especially post-pandemic and due to reduced dependency on Chinese chemical suppliers. --- ### **Strategic Focus & Growth Strategy: '3I' Framework** SHK’s long-term growth is anchored on the **‘3I’ strategy**: 1. **India** – R&D, backward integration, and domestic leadership hub. 2. **Italy** – Anchors European operations via **Creative Fragrances & Flavours (CFF)** and **Holland Aromatics**, enhancing access to Western Europe. 3. **Indonesia** – Gateway to ASEAN markets with a greenfield manufacturing plant in **Jakarta**, improving regional supply chain resilience and speed-to-market. This framework supports market expansion, innovation, and integration across geographies. --- ### **Global Presence & Manufacturing Footprint** - **Manufacturing Facilities**: Five key sites in India (Vapi, Vashivali, Mahad), Italy (Milan), and Indonesia (Jakarta). Total capacity allows for **significant scalability** — Indian plants operate below full utilization (~50–55%) with potential to triple output with minimal capex. - **In-house Manufacturing**: A key differentiator. SHK owns all core manufacturing, unlike peers relying on outsourcing. This ensures **quality control, IP protection, cost efficiency, and long-term scalability**. - **Backward Integration**: Invests heavily in securing raw material supply, including cultivation of **Vetiver and Geranium oil** in India via **Keva Aromatics**, reducing reliance on geopolitically sensitive regions like Haiti and China. --- ### **R&D & Innovation Leadership** SHK distinguishes itself through **technology-led innovation**: - Operates **seven+ Creation & Development Centres (CDCs)** globally in **India, Singapore, Italy, Germany, Netherlands, UK (Manchester), and Indonesia**. - Launched new CDCs in **Germany (2024)** and **Manchester, UK (2025)**, with a **fully operational U.S. development center** in New Jersey supporting North American clients. - The U.S. center, while not a manufacturing hub, enables **faster turnaround and deeper engagement with U.S.-based MNCs** using **tolling or local contract manufacturing**. - Over the past 5 years: - Developed **17 proprietary molecules**. - Filed **20 patent applications**, with **6 commercially exploited** in deodorants and fine fragrances. - Only Indian-origin F&F company to file patents in **fragrance and novel aroma molecules**. --- ### **Acquisitions & Inorganic Growth** Strategic acquisitions have strengthened SHK’s global footprint: - **CFF (Italy)**: Acquired 100% stake in 2020 (~₹223 crore), a premium fine fragrance and fabric care player with strong European distribution. - **Nova Fragranze (Italy)**: 70% stake acquired in 2021, enhancing presence in high-margin beauty and hair care fragrances. - **Holland Aromatics (Netherlands)**: Acquired 62% in early 2022, full ownership by 2024 — strengthens **Northern European market access** and positions SHK as a key supplier to MNCs. - **NuTaste (India)**: Expanded into ready-to-use flavors for **QSR, canteens, and food delivery**, with a focus on **savory seasonings and syrups**. These acquisitions have created **cross-selling opportunities, operational synergies, and enhanced client engagement in Europe**. --- ### **Client Base & Market Penetration** - Serves **4,000+ medium to large FMCG companies**, including **Unilever, Danone, Nestlé, Britannia, Mondelez**, and emerging **D2C and e-commerce brands**. - **>95% repeat business** with **no long-term contracts** — client retention driven by **product quality, IP ownership, and consumer success**. - Revenue highly diversified: - **Top 3 customers** account for only ~10% of total revenue. - Over **90% of business is proprietary**, giving high customer stickiness. - Actively engaging with **global MNCs**: - Secured multi-year contracts with a **major global FMCG client**, doubling FY25 order book. - Became a **pre-qualified vendor** for global tenders; targeting **20% win rate** from a $100M annual opportunity pool. - Gaining traction in **U.S., Middle East, and Africa**, with dedicated sales offices planned in **UAE**. --- ### **Recent Developments (2025)** - **New U.S. Development Center**: Fully operational in **New Jersey**, enhancing presence in the **world’s largest F&F market** ($10B+ TAM). Supports U.S. clients with faster innovation cycles and tariff-resilient supply. - **UK CDC in Manchester**: Complements German CDC, deepening R&D capacity in **Western Europe**, especially UK, France, and MENA. - **Greenfield Facility in Vanavate**: To be commissioned by **end-2025**, consolidating leased operations, improving efficiency, and reducing working capital. - **Expansion in Industrial Fragrances**: Growing segment in **automotive accessories and consumer electronics**, with steady growth in India and Asia. --- ### **Market Trends & Strategic Positioning** - **Consumer Shifts**: Driving demand for **clean-label, natural, premium, and health-oriented** products. - **Supply Chain Diversification**: Global shift away from China benefits SHK, especially in **Global Ingredients**. - **Sustainability Initiatives**: - Developed **Santalol**, a **biosustainable alternative to sandalwood oil** in partnership with BASF/Isobionics. - Focus on **biodegradable molecules** via **Plant Biotechnology and Microbiology divisions**. - In-house **safety testing and AI-driven product development** accelerating innovation.